Powered driver

Abstract
An apparatus and methods are provided to penetrate a bone and associated bone marrow using a powered driver having a gear assembly and a motor. The powered driver may include an indicator operable to show status of a power supply associated with the powered driver. The power supply may include a battery power pack having a diamond shaped cross section. The powered driver may have a handle with a corresponding cross section.
Description
TECHNICAL FIELD

The present disclosure is related to apparatus for penetrating a bone and associated bone marrow with a powered driver and inserting a intraosseous device into the bone marrow.


BACKGROUND OF THE DISCLOSURE

Every year, millions of patients are treated for life-threatening emergencies in the United States. Such emergencies include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, burns, and status epilepticus just to name a few. For example, according to the American Heart Association, more than 1,500,000 patients suffer from heart attacks (myocardial infarctions) every year, with over 500,000 of them dying from its devastating complications.


Obtaining satisfactorily vascular access may be a critical problem in approximately five (5%) percent to ten (10%) percent of patients treated in either prehospital or hospital settings. In the U.S. approximately six million patients annually may experience problems with traditional intravenous access. An essential element for treating medical emergencies is rapid establishment of an intravenous (IV) line to administer drugs and fluids directly into the circulatory system. Whether in an ambulance by paramedics, or in an emergency room by emergency specialists, the goal is the same—start an IV in order to administer life-saving drugs and fluids. To a large degree, the ability to successfully treat such critical emergencies is dependent on skill and luck of an operator in accomplishing vascular access.


While it is relatively easy to start an IV on many patients, doctors, nurses and paramedics often experience great difficulty establishing IV access in some patients. These patients are probed repeatedly with sharp needles in an attempt to solve this problem and may require an invasive procedure to finally establish an intravenous route. A further complicating factor in achieving IV access occurs “in the field” e.g. at the scene of an accident or during ambulance transport where it is difficult to see the target and excessive motion make accessing the venous system very difficult.


In the case of patients with chronic disease or the elderly, the availability of easily-accessible veins may be depleted. Other patients may have no available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration or previous IV drug use. For these patients, finding a suitable site for administering lifesaving drugs becomes a monumental and frustrating task. While morbidity and mortality statistics are not generally available, it is known that many patients with life-threatening emergencies have died of ensuing complications because access to the vascular system with life-saving IV therapy was delayed or simply not possible. For such patients, an alternative approach is required.


Powered drivers associated with intraosseous (IO) devices typically include a housing with various types of motors and/or gear assemblies disposed therein. A rotatable shaft may be disposed within the housing and connected with a gear assembly. Various types of fittings, connections, connectors and/or connector receptacles may be provided at one end of the rotatable shaft extending from the housing to releasably engage an IO device with the powered driver.


Examples of powered drivers are shown in pending patent application Ser. No. 10/449,503 filed May 30, 2003 entitled “Apparatus and Method to Provide Emergency Access To Bone Marrow,” now U.S. Pat. No. 7,670,328; Ser. No. 10/449,476 filed May 30, 2003 entitled “Apparatus and Method to Access Bone Marrow,” now U.S. Pat. No. 7,699,850; and Ser. No. 11/042,912 filed Jan. 25, 2005 entitled “Manual Intraosseous Device,” now U.S. Pat. No. 8,641,715.


SUMMARY OF THE DISCLOSURE

In accordance with teachings of the present disclosure, powered drivers are provided for use in gaining rapid access to a patient's vascular system. One embodiment may include a powered driver operable to insert an intraosseous device into a patient's bone marrow at a selected target site. The powered driver may include a power supply operable to make at least five hundred (500) insertions of an intraosseous device into bone and associated bone marrow. For some embodiments the associated power supply may be operable to make over one thousand (1000) insertions. For some applications a powered driver incorporating teachings of the present disclosure may have the general configuration of a small pistol.


One embodiment of the present disclosure may include providing emergency vascular access (EVA) by inserting a penetrator assembly into a bone and associated bone marrow by means of a powered driver, detaching the powered driver from the penetrator assembly, removing an inner penetrator from an outer penetrator of the penetrator assembly and attaching an adapter suitable to communicate medications or fluids with the bone marrow.


Another embodiment of the present disclosure may include manufacturing a powered driver, operable to penetrate bone and associated bone marrow, by forming a housing having a drive shaft extending from one end of the housing. A connector may be formed on the one end of the drive shaft to releasably attach a penetrator assembly to the drive shaft. A gear assembly may be disposed within the housing and rotatably engage with the drive shaft. A motor may be disposed within the housing and rotatably engaged to the gear assembly opposite from the drive shaft. A power supply and associated electrical circuitry operable to power the motor may also be disposed within the housing.


Powered drivers incorporating various teachings of the present disclosure may be used to provide intraosseous access to a patient's vascular system in the sternum, the proximal humerus (the shoulder area), the proximal tibia (below the knee) and the distal tibia (above the inside of the ankle).


A motor and gear assembly may be disposed within a housing and may be operable to rotate the drive shaft at approximately twelve hundred (1200) revolutions per minute (RPM). The gear assembly may reduce rotation speed of the motor by a ratio of approximately twenty to one (20:1). A trigger or on/off switch may extend from the housing. For some embodiments a five battery power pack may be disposed within the housing. For other embodiments a four battery power pack may be disposed within the housing. Some embodiments may include an over current fuse operational to reduce the chance of overheating of the batteries and/or power pack.


For some embodiments a powered drive may include a housing having a trigger operable to activate a motor disposed within the housing. A removable trigger guard may be disposed over the trigger when the powered driver is not in use. A lanyard may be used to securely engage the removable trigger guard with the housing. The length of the lanyard may be selected to accommodate placing the trigger guard over the trigger to prevent accidental activation and removing the trigger guard from covering the trigger to allow activation of the motor.


For some embodiments a powered driver may be provided with a housing having a motor and a gear assembly disposed therein. Sound dampening may be disposed within the housing to reduce noise associated with operation of the motor and gear assembly. A power supply status light may be provide at a proximal end of the housing indicate if the battery power is satisfactory (green light) or may be failing (red light). In one embodiment, the light will remain green so long as there is more than 10% of battery power remaining, once 90% of the battery power has been drained the light will turn red.


Another aspect of the present disclosure may include forming a sealed housing to prevent blood and/or other body fluids from contaminating interior portions of the housing and associated components such as the battery, motor and/or reduction gear assembly. A trigger mechanism or operating switch assembly may also be sealed with the housing to prevent contamination from blood and/or other fluids. Rubber or other elastomeric material may be used to from a flexible, fluid seal over the trigger mechanism or operating switch assembly.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete and thorough understanding of the present embodiments and advantages thereof may be acquired by referring to the following description taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features, and wherein:



FIG. 1A is a schematic drawing showing an isometric view of one embodiment of a powered driver incorporating teachings of the present disclosure;



FIG. 1B is a schematic drawing showing a distal end view of the powered driver of FIG. 1A;



FIG. 1C is a schematic drawing in section and in elevation taken along lines 1C-1C OF FIG. 1B showing one example of a power supply incorporating teachings of the present disclosure.



FIG. 1D is a schematic drawing in section showing one example of a powered drive having sound dampening materials in accordance with teachings of the present disclosure;



FIG. 1E is a schematic drawing taken along lines 1E-1E of FIG. 1B showing one example of a four battery power supply having a generally diamond shaped cross section;



FIG. 2A is a schematic drawing showing an isometric view of a powered drive including a trigger guard and a lanyard attached thereto in accordance with teachings of the present disclosure;



FIG. 2B is a schematic drawing in section and in elevation showing a powered driver having a power source, a trigger, electrical circuits, a motor and a gear assembly incorporating various teachings of the present disclosure;



FIG. 2C is a schematic drawing showing a trigger guard in accordance with teachings of the present disclosure;



FIG. 3 is a schematic drawing in section and in elevation with portions broken away showing another example of a powered drive having a housing, trigger assembly, motor, reduction gear and power source incorporating teachings of the present disclosure;



FIG. 4A is a schematic drawing showing one example of an intraosseous needle set or penetrator assembly which may be inserted into a patient's vascular system using a powered driver incorporating teachings of the present disclosure;



FIG. 4B is a schematic drawing showing an isometric view with portions broken away of a connector receptacle which may be releasably engaged with a powered driver incorporating teachings of the present disclosure;



FIG. 5A is a schematic drawing in section with portions broken away showing one example of a protective cover in a first position blocking access to a trigger of a powered driver incorporating teachings of the present disclosure;



FIG. 5B is a schematic drawing showing the protective cover of FIG. 5A in a second position allowing access to the trigger of the powered driver;



FIG. 5C is an isometric drawing showing another example of a trigger guard in a first position blocking access to a trigger of a powered driver incorporating teachings of the present disclosure; and



FIG. 5D is a schematic drawing showing the trigger guard of FIG. 5C in a second position allowing access to the trigger of the powered driver.





DETAILED DESCRIPTION OF THE DISCLOSURE

Preferred embodiments of the disclosure and its advantages may be best understood by reference to FIGS. 1A-5D wherein like numbers refer to same and like parts.


Vascular system access may be essential for treatment of many serious diseases, chronic conditions and acute emergency situations. Yet, many patients experience extreme difficulty obtaining effective treatment because of inability to obtain or maintain intravenous (IV) access. An intraosseous (IO) space provides a direct conduit to a patent's vascular system and systemic circulation. Therefore, IO access is generally an effective route to administer a wide variety of drugs, other medications and fluids equivalent to IV access. Rapid IO access or emergency vascular access (EVA) offers great promise for almost any serious emergency that requires vascular access to administer life saving drugs, other medications and/or fluids when traditional IV access is difficult or impossible.


Bone marrow typically includes blood, blood forming cells, and connective tissue disposed in an intraosseous space or cavity surrounded by compact bone. Long bones such as the tibia typically have an elongated central cavity filled with yellow bone marrow and adipose or connective tissue. Such cavities may also be referred to as a “medullary cavity”, “bone marrow cavity” and/or “intraosseous space.”


Compact bone disposed near an anterior or dorsal surface may be referred to as “anterior compact bone” or “anterior bone cortex.” Compact bone disposed farther from the dorsal or anterior surface may be referred to as “posterior compact bone” or “posterior bone cortex.”


The upper tibia proximate a patient's knee or the humeral head proximate a patient's shoulder may be used as insertion sites for an IO device to establish access with the patient's vascular system. Sternal access may also be used as an insertion site. Availability of multiple intraosseous insertion sites and associated target areas in adjacent bone marrow have proven to be especially important in applications such as emergency treatment of battlefield casualties or other mass casualty situations. Teachings of the present disclosure may be used to obtain intraosseous access at a wide variety of insertion sites and target areas.


IO access may be used as a “bridge” for temporary fluid and/or drug therapy during emergency conditions until conventional IV sites can be found and used. Conventional IV sites often become available because fluids and/or medication provided via IO access may stabilize a patient and expand veins and other portions of a patient's vascular system. IO devices and associated procedures incorporating teachings of the present disclosure may become standard care for administering medications and fluids in situations when IV access is difficult or not possible.


Intraosseous access may be used as a “routine” procedure with chronic conditions which substantially reduce or eliminate availability of conventional IV sites. Examples of such chronic conditions may include, but are not limited to, dialysis patients, patients in intensive care units and epilepsy patients. Intraosseous devices and associated apparatus incorporating teachings of the present disclosure may be quickly and safely used to provide IO access to a patient's vascular system in difficult cases such as status epilepticus to give medical personnel an opportunity to administer crucial medications and/or fluids. Further examples of such acute and chronic conditions are listed near the end of this written description.


Apparatus and methods incorporating teachings of the present disclosure may include using a first IO needle set having a fifteen (15) gage cannula with a length of approximately fifteen (15) millimeters to establish vascular access for patients weighing between approximately three (3) kilograms and thirty nine (39) kilograms. A second IO needle set having a fifteen (15) gage cannula with an approximate length of twenty-five (25) millimeters may be used to establish vascular access for patients weighing forty (40) kilograms and greater.


The term “driver” may be used in this application to include any type of powered driver satisfactory for inserting an intraosseous (IO) device such as a penetrator assembly, a catheter, an IO needle or an IO needle set into a selected portion of a patient's vascular system. Various techniques may be satisfactorily used to releasably engage or attach an IO device with a driver incorporating teachings of the present disclosure. A wide variety of connectors and associated connector receptacles, fittings and/or other types of connections with various dimensions and configurations may be satisfactorily used to releasably engage an IO device with a driver. A battery powered driver incorporating teachings of the present disclosure may be used to insert an intraosseous device into a selected target area in ten seconds or less. The reduced size and weight of drivers incorporating teachings of the present disclosure may accommodate use in emergency medical vehicles and emergency crash carts at medical facilities and/or carrying in backpacks of military personnel deployed for extended periods of time in remote locations.


The term “intraosseous (IO) device” may be used in this application to include any hollow needle, hollow drill bit, penetrator assembly, bone penetrator, catheter, cannula, trocar, inner penetrator, outer penetrator, IO needle or IO needle set operable to provide access to an intraosseous space or interior portions of a bone.


For some applications an IO needle or IO needle set may include a connector with a trocar or stylet extending from a first one end of the connector. A second end of the connector may be operable to be releasably engaged with a powered driver incorporating teachings of the present disclosure. An IO needle or IO needle set may also include a hub with a hollow cannula or catheter extending from a first end of the hub. A second end of the hub may include an opening sized to allow inserting the trocar through the opening and the attached hollow cannula. The second end of the hub may be operable to be releasably engaged with the first end of the connector. As previously noted, the second end of the connector may be releasably engaged with a powered driver. A wide variety of connectors and hubs may be used with an IO device incorporating teaching of the present disclosure. The present disclosure is not limited to connector 180 or hub 200 as shown in FIGS. 4A and 4B.


Various features of the present disclosure may be described with respect to powered drivers 230a-230d, 330a and 330b (See FIG. 3). Various features of the present disclosure may also be described with respect to intraosseous device 160 such as shown in FIGS. 4A and 4B. However, the present disclosure is not limited to use with intraosseous device 160 or powered drivers 230a-230d, 330a and 330b.


Powered driver 230a as shown in FIGS. 1A, 1B, 1C, and 1E may be satisfactorily used to insert an intraosseous device at a desired insertion site adjacent to a bone and associated bone marrow. Powered driver 230a as shown in FIGS. 1A, 1B, 1C, and 1E may include one or more features of the present disclosure. At least one or more features of the present disclosure may also be shown with respect to powered drivers 230b, 230c, 230d, 330a, and 330b (See FIG. 3).


Powered driver 230a may include housing 232 having the general configuration of a small pistol defined in part by handle 236. Various components associated with powered driver 230a may be disposed within housing 232 including handle 236. For example a power source such as battery pack 234 may be disposed within handle 236. Battery pack 234 may have various configurations and may include multiple batteries 238 disposed within sealed packaging material 240 (See FIG. 1E). For purposes of describing various features of the present disclosure sealed packaging material 240 is not shown in FIGS. 1C, 1D and 2A.


Handle 236 may be generally described as an elongated, hollow container sized to receive battery pack or power supply 234 therein. Housing 230a including handle 236 may be formed from relatively strong, heavy duty polymeric material. For some applications housing 232 may be formed in two halves which are joined together to form a fluid tight seal with the various components associated with powered driver 230a disposed therein. For such applications power source or power supply 234 may include disposable batteries. In other embodiments, handle 236 may include exterior connections configured to allow recharging of power supply 234.


Motor 244 and gear assembly 246 may be disposed within portions of housing 232 adjacent to handle 236. For embodiments represented by powered drivers 230a-e, respective motor 244 and gear assembly 246 may be generally aligned with each other. Motor 244 may be rotatably engaged with one end of gear assembly 246. Drive shaft 250 may be rotatably engaged with and extend from another end of gear assembly 246 opposite from motor 244.


Distal end or first end 248 of housing 232 may include opening (not expressly shown) with portions of drive shaft 250 extending therefrom. For some applications end 252 of drive shaft 250 extending from housing 232 may have a generally pentagonal shaped cross section with tapered surfaces 256 disposed thereon. Tapered surfaces 256 may be disposed at an angle of approximately three (3°) degrees with respect to a longitudinal axis or rotational axis (not expressly shown) associated with drive shaft 250. Relatively small magnet 257 disposed on the extreme end of drive shaft 250 opposite from distal end 248 of housing 232. Fittings and/or connectors with various dimensions and/or configurations other than end 252 of drive shaft 250 and/or magnet 257 may also be satisfactorily used with a powered driver incorporating teachings of the present disclosure.


Intraosseous devices having corresponding tapered openings or connector receptacles may be releasably engaged with end 252 of drive shaft 250 extending from housing 232. For example, end 252 extending from distal end 248 of housing 232 may be releasably engaged with tapered opening 186 in connector 180 as shown in FIGS. 4A and 4B. Tapered opening 186 and end 252 of drive shaft 250 preferably have non-sticking tapers.


For some applications both motor 244 and gear assembly 246 may have generally cylindrical configurations. Exterior portion 245 of motor 244 may correspond with the largest outside diameter or nominal outside diameter associated with motor 244. Exterior portion 247 of gear assembly 246 may correspond with the largest outside diameter or nominal outside diameter associated with gear assembly 246. For embodiments of the present disclosure represented by powered drivers 230a-230b, exterior portion 245 of motor 244 may have a nominal outside diameter portion larger than any outside diameter portion associated with gear assembly 246.


Portions of housing 232 may have generally similar cylindrical configurations corresponding with exterior portions of motor 244 and gear assembly 246. For example, segment 232a of housing 232 may have a generally cylindrical, hollow configuration with an inside diameter compatible with exterior portion 245 of motor 244. Housing segment 232b may have a generally cylindrical, hollow configuration with an inside diameter compatible with exterior portion 247 of gear assembly 246. Since portions of motor 244 have an outside diameter that is larger than the outside diameter of any portion of gear assembly 246, housing segment 32a may have a larger outside diameter than the outside diameter of housing segment 32b.


Motors and gear assemblies satisfactory for use with a powered driver incorporating teachings of the present disclosure may be obtained from various vendors. Such motor and gear assemblies are typically ordered as “sets” with one end of each motor securely attached to an adjacent end of an associated gear assembly. A drive shaft having various dimensions and/or configurations may extend from the gear assembly opposite from the motor. The gear assemblies may sometimes be referred to as “reduction gears” or “planetary gears”. The dimensions and/or configurations of an associated housing may be modified to accommodate an associated motor and gear assembly.


For some applications a thrust pad structure 295 may be disposed between proximal end 249 of housing 232 and adjacent portions of motor 244. The thrust pad structure 297 may also be disposed adjacent to distal end 248 of housing 232. Thrust pad structures 295 and 297 may limit longitudinal movement of motor 244, gear assembly 246 and drive shaft 250 within associated portions of housing 232. Thrust pad structures 295 and 297 are also shown in FIGS. 1C and 1F. In some embodiments, thrust pad structure 295 may include one or more fixed portions of motor 244 configured to locate motor 244 in relation to housing 232.


For embodiments represented by power driver 230b as shown in FIG. 1D sound damping material 296 may be disposed adjacent to proximal end 249 of housing 232. One of the features of the present invention may include placing sound damping material at various locations within a housing to reduce noise associated with operating a powered driver while inserting an intraosseous device into a target area.


For embodiments of the present disclosure such as shown in FIG. 1D powered driver 230b may include electronic circuit board or smart board 274. Electrical circuit board 274 may also provide an electronic safety switch operable to turn off or deenergize motor 244 after power driver 230b has been energized for a selected amount of time. For example, electronic circuit board 274 may turn off power driver 230b after approximately ten seconds. For other applications, electronic circuit board 274 may turn off motor 244 after 20 seconds of operations. The time period for deenergizing motor 244 may be selected to save energy in an associated power source.


Powered drivers incorporating teaching of the present disclosure may typically run only a few seconds during insertion of an intraosseous device into bone and associated bone marrow. Activation of an associated motor for a longer period of time may imply a malfunction or use of the powered driver for other than normal IO insertion. To prevent draining of batteries, the timeout or timing circuit may automatically turn off the motor after a set time period such as ten (10) seconds or twenty (20) seconds. The time period may correspond with the length of time required to charge the capacitor shown in the above drawing. The timeout or timing circuit may function as a battery saving device. The timeout or timing circuit may be particularly important when a powered driver is carried in a tool box or a backpack to prevent accident draining of the battery.


Additional embodiments of the present disclosure are shown in FIGS. 2A, 2B, and 2C. For such embodiments trigger guard 290 may be releasably disposed over portions of trigger assembly 262d extending from housing 232d. Trigger guard 290 as shown in FIG. 2A may be formed from relatively strong but flexible material. Trigger guard 290 may have a generally U shaped configuration with ribs 292 formed on opposite sides of trigger guard 290. When trigger guard 290 is disposed over end or button 264d of trigger assembly 292d, ribs 292 will preferably be disposed immediately adjacent to portions of handle 236. A pair of ribs 292 disposed on opposite sides of trigger guard 290 may be used to easily release trigger guard 290 from covering trigger assembly 262d. By placing respective ribs 292 on opposite sides of trigger guard 290, either the thumb (not expressly shown) of an operator's left hand or right hand may be used to remove trigger guard 290.


Another aspect of the present disclosure may include attaching a trigger guard with a housing a lanyard. For example, lanyard 296 as shown in FIG. 2A may be formed from various types of flexible, light weight material. First end 297 of lanyard 296 may be securely engaged with an appropriately sized opening formed in trigger guard 290. Second end 298 of lanyard 296 may be securely engaged on the end of handle 236. As a result of using lanyard 296, an operator may quickly release trigger guard 290 from power driver 230c but will avoid losing trigger guard 290.


As shown in FIG. 2A, power driver 230c may also include electrical circuit board 274d operable to activate light 280. Powered drive 230c as shown in FIGS. 1A-E, 2A-B, and 3 may include light 280 operable to indicate the status of power supply 240d disposed within handle 236. Light 280 may be disposed at proximal end or second end 249 of powered driver 230c. For some applications light 280 may be activated when button 264 of trigger assembly 262 is activated or depressed. A green light may be used to indicate that battery pack 234b has sufficient power to activate motor 244 and gear assembly 246. A red light may be visible at indicator 280 to indicate that battery power 234b may be failing. A wide variety of indicators including, but not limited to, light emitting diodes (LED's), liquid crystal displays (LCD's) and small more conventional light bulbs may be satisfactorily used with a powered driver according to teachings of the present disclosure. In some embodiments, indicators may be covered by a user's hand when in use to avoid visibility (e.g., in some military situations).


Additional embodiments of the present disclosure are shown in FIG. 3. For such embodiments a power supply 234b may include five batteries 238. The embodiment of the present disclosure as represented by powered driver 230c may also include one or more of the electronic circuit boards.


Penetrator assembly 160 as shown in FIGS. 4A and 4B may include connector 180, and associated hub 200, outer penetrator 210 and inner penetrator 220. Penetrator assembly 160 may include an outer penetrator such as a cannula, hollow tube or hollow drill bit and an inner penetrator such as a stylet or trocar. Various types of stylets and/or trocars may be disposed within an outer penetrator. For some applications outer penetrator or cannula 210 may be described as a generally elongated tube sized to receive inner penetrator or stylet 220 therein. Portions of inner penetrator 220 may be disposed within longitudinal passageway 184 extending through outer penetrator 210. The outside diameter of inner penetrator 220 and the inside diameter of longitudinal passageway 184 may be selected such that inner penetrator 220 may be slidably disposed within outer penetrator 210.


Metallic disc 170 may be disposed within opening 186 for use in releasably attaching connector 180 with magnet 257 disposed on end 252 of drive shaft 252. End 223 of inner penetrator 220 may be spaced from metallic disc 170 with insulating or electrically nonconductive material disposed therebetween.


Tip 211 of outer penetrator 210 and/or tip 222 of inner penetrator 220 may be operable to penetrate bone and associated bone marrow. The configuration of tips 211 and/or 222 may be selected to penetrate a bone or other body cavities with minimal trauma. First end or tip 222 of inner penetrator 220 may be trapezoid shaped and may include one or more cutting surfaces. In one embodiment outer penetrator 210 and inner penetrator 220 may be ground together as one unit during an associated manufacturing process. Providing a matching fit allows respective tips 211 and 222 to act as a single drilling unit which facilitates insertion and minimizes damage as portions of penetrator assembly 160 are inserted into a bone and associated bone marrow. Outer penetrator 210 and/or inner penetrator 220 may be formed from stainless steel, titanium or other materials of suitable strength and durability to penetrate bone.


Hub 200 may be used to stabilize penetrator assembly 160 during insertion of an associated penetrator into a patient's skin, soft tissue and adjacent bone at a selected insertion site. First end 201 of hub 200 may be operable for releasable engagement or attachment with associated connector 180. Second end 202 of hub 200 may have a size and configuration compatible with an associated insertion site for outer penetrator 210. The combination of hub 200 with outer penetrator 210 may sometimes be referred to as a “penetrator set” or intraosseous needle.


Connector 180 and attached inner penetrator 220 may be releasably engaged with each other by Luer type fittings, threaded connections or other suitable fittings formed on first end 201 of hub 200. Outer penetrator 210 extends from second end 202 of hub 200.


For some applications connector 180 may be described as a generally cylindrical tube defined in part by first end 181 and second end 182. The exterior of connector 180 may include an enlarged tapered portion adjacent to end 181. A plurality of longitudinal ridges 190 may be formed on the exterior of connector 180 to allow an operator to grasp associated penetrator assembly 160 during attachment with a drive shaft. Longitudinal ridges 190 also allow connector 180 to be grasped for disengagement from hub 200 when outer penetrator 210 has been inserted into a bone and associated bone marrow.


Second end 182 of connector 180 may include opening 185 sized to receive first end 201 of hub 200 therein. Threads 188 may be formed in opening 185 adjacent to second end 182 of connector 180. Threaded fitting 188 may be used in releasably attaching connector 180 with threaded fitting 208 adjacent to first end 201 of hub 200.


First end 201 of hub 200 may include a threaded connector 208 or other suitable fittings formed on the exterior thereof. First end 201 may have a generally cylindrical pin type configuration compatible with releasably engaging second end or box end 182 of connector 180.


For some applications end 202 of hub 200 may have the general configuration of a flange. Angular slot or groove 204 sized to receive one end of protective cover or needle cap 234 may be formed in end 202. Slot or groove 204 may be used to releasable engage a needle cover (not expressly shown) with penetrator assembly 160.


For some applications a penetrator assembly may include only a single, hollow penetrator. For other applications a penetrator assembly may include an outer penetrator such as a cannula, hollow needle or hollow drill bit and an inner penetrator such as a stylet, trocar or other removable device disposed within the outer penetrator. Penetrator 210 is one example of a single, hollow penetrator or cannula.


The size of a penetrator may vary depending upon the intended application for the associated penetrator assembly. Penetrators may be relatively small for pediatric patients, medium size for adults and large for oversize adults. By way of example, a penetrator may range in length from five (5) mm to thirty (30) mm. The diameter of a penetrator may range from eighteen (18) gauge to ten (10) gauge. The length and diameter of the penetrator used in a particular application may depend on the size of a bone to which the apparatus may be applied. Penetrators may be provided in a wide variety of configurations depending upon intended clinical purposes for insertion of the associated penetrator. For example, there may be one configuration for administering drugs and/or fluids to a patient's bone marrow and an alternative configuration for sampling bone marrow and/or blood from a patient. Other configurations may be appropriate for bone and/or tissue biopsy.


For some applications connector 180 may be described as having a generally cylindrical configuration defined in part by first end 181 and second end 182. Exterior portions of connector 180 may include an enlarged tapered portion adjacent to end 181. A plurality of longitudinal ridges 190 may be formed on the exterior of connector 180 to allow an operator to grasp associated penetrator assembly 160 during attachment with a drive shaft. Longitudinal ridges 190 also allow connector 180 to be grasped for disengagement from hub 200 when outer penetrator 210 has been inserted into a bone and associated bone marrow.


First end 181 of connector of 180 may included opening 186 sized to receive portions drive shaft 52 therein. A plurality of webs 136 may extend radially outward from connector receptacle 186. Webs 136 cooperate with each other to form a plurality of openings 138 adjacent to first end 181. Opening 186 and openings 138 cooperate with each other to form portions of a connector receptacle operable to receive respective portions of a connector (not expressly shown) therein.



FIG. 5A-5D show further examples of trigger guards which may be used with a powered driver in accordance with teachings of the present disclosure. Power drivers 330a and 330b may include cap 338 disposed on one end of handle 336. Cap 338 may be used to replace a power supply (not expressly shown) disposed within handle 336.


For some embodiments a trigger guard may be slidably disposed on portions of a handle adjacent to an associated trigger assembly. For example, FIG. 5A shows power driver 330a with trigger guard 390a in its first position covering portions of trigger assembly 362. In FIG. 5B, trigger guard 390a is shown in its second position which allows access to trigger assembly 362 for operation of power driver 330a. For such embodiments, trigger guard 390a may be described as having a generally elongated configuration with a U shaped cross section. The profile of the U shaped cross section of trigger guard 390a may be selected to correspond with adjacent portions of handle 336 and trigger assembly 362. The length of trigger guard 390a may correspond approximately to the length of adjacent portion of handle 336.


For embodiments represented by power driver 330b as shown in FIGS. 5C and 5D, trigger guard 390b may have a generally U shaped configuration similar to corresponding portions of trigger guard 390a. However, the length of trigger guard 390b may be substantially less than the length of trigger guard 390a. For embodiments such as shown in FIGS. 5C and 5D, pivot pin 392 may be disposed between portions of trigger guard 390b and adjacent portions of handle 396. Pivot pin 392 may allow rotational movement of trigger guard 390b from a first position blocking access to trigger assembly 362 as shown in FIG. 5C and a second position allowing access to trigger assembly 362 as shown in FIG. 5D.


Examples of acute and chronic conditions which may be treated using powered drivers, intraosseous devices, and procedures incorporating teachings of the present disclosure include, but are not limited to, the following:

    • Anaphylaxis (epinephrine, steroids, antihistamines, fluids, and life support)
    • Arrhythmia (anti-arrhythmics, electrolyte balance, life support);
    • Burns (fluid replacement, antibiotics, morphine for pain control);
    • Cardiac arrest (epinephrine, atropine, amiodarone, calcium, xylocaine, magnesium);
    • Congestive heart failure (life support, diuretics, morphine, nitroglycerin);
    • Dehydration (emergency port for life support, antibiotics, blood, electrolytes);
    • Diabetic Ketoacidosis (life support, electrolyte control, fluid replacement);
    • Dialysis (emergency port for life support, antibiotics, blood, electrolytes);
    • Drug overdose (naloxone, life support, electrolyte correction);
    • Emphysema (life support, beta adrenergics, steroids);
    • Hemophiliacs (life support, blood, fibrin products, analgesics);
    • Osteomyelitis (antibiotics directly into the site of infection, analgesics);
    • Pediatric applications (shock, dehydration, nutrition, electrolyte correction);
    • Renal Failure (both acute and chronic kidney failure, inability to purify blood);
    • Seizures (anti-seizure medications, life support, fluid balance);
    • Shock (life support fluids, pressor agents, antibiotics, steroids);
    • Sickle cell crisis (fluid, morphine for pain, blood, antibiotics); and
    • Trauma (emergency port for life support fluids, antibiotics, blood, electrolytes).


Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions and alternations can be made herein without departing from the spirit and scope of the disclosure as defined by the following claims.

Claims
  • 1. A removable trigger guard comprising: a body having a U-shaped cross-section, the body having first and second ends and first and second sides extending between the first and second ends, where the second end is closed such that the first and second sides are connected by the second end, and where an opening is defined through the first end to accept a trigger assembly of a powered driver; anda pair of ribs disposed on the first and second sides of the trigger guard, each of the ribs extending outwardly from the respective side and away from the other of the pair of ribs;the ribs configured to be contacted by a thumb of an operator ove the trigger guard from covering portions of the trigger assembly of the powered driver;the trigger guard configured to be removably coupled to the powered driver that includes the trigger assembly, the trigger assembly having an external surface configured to be depressed to activate the powered driver, the first and second sides of the trigger guard configured to cover opposing lateral sides of the trigger assembly and the second end of the trigger guard configured to cover a front of the trigger assembly to prevent the trigger assembly from being depressed and to prevent operation of the powered driver when the trigger guard is coupled to the powered driver;where portions of the first and second sides of the trigger guard form a flush surface with a surface of the handle of the powered driver when the trigger guard is coupled to the powered driver.
  • 2. The removable trigger guard of claim 1, further comprising: a lanyard having a first end coupled to the body and a second end configured to be coupled to the powered driver.
  • 3. The removable trigger guard of claim 2, further comprising an opening configured to receive the first end of the lanyard.
  • 4. The removable trigger guard of claim 2, where the lanyard is formed of a flexible material.
  • 5. The removable trigger guard of claim 1, where the trigger guard is formed of a flexible material.
  • 6. The removable trigger guard of claim 1, where the trigger guard is further configured to be slidably disposed on a portion of the handle of the powered driver.
  • 7. The removable trigger guard of claim 1, where portions of the trigger guard comprise a shape that corresponds with adjacent portions of the handle of the powered driver when the trigger guard is coupled to the powered driver and covers the trigger assembly of the powered driver.
  • 8. The removable trigger guard of claim 1, where the trigger guard extends a longitudinal length of the handle of the powered driver.
  • 9. The removable trigger guard of claim 1, where the trigger guard extends less than a longitudinal length of the handle of the powered driver.
  • 10. The removable trigger guard of claim 1, further comprising a pivot pin, the pivot pin configured to couple the trigger guard to a portion of the handle of the powered driver.
  • 11. The removable trigger guard of claim 10, the trigger guard configured to rotate between a first position and a second position, where the trigger guard covers the trigger assembly in the first position.
  • 12. The removable trigger guard of claim 1, where a portion of the trigger guard is adjacent to a cap of the powered driver when the trigger guard is coupled to the powered driver and covers the trigger assembly of the powered driver, the cap of the powered driver configured to control access to a power supply disposed within the handle of the powered driver.
  • 13. The removable trigger guard of claim 12, where portion of the trigger guard adjacent to the cap forms a flush surface with the cap when the trigger guard is coupled to the powered driver and covers the trigger assembly of the powered driver.
  • 14. The removable trigger guard of claim 1, where the ribs are disposed adjacent to a handle of the powered driver when the trigger guard is coupled to the powered driver.
RELATED APPLICATION

This application claims priority to U.S. Provisional Patent Application Ser. No. 60/910,147, filed Apr. 4, 2007, and entitled “Powered Driver”. The contents of U.S. patent application Ser. No. 10/449,476, filed May 30, 2003; U.S. patent application Ser. No. 11/253,959, filed Oct. 19, 2008; U.S. patent application Ser. No. 11/253,467, filed Oct. 19, 2008; and U.S. Provisional Patent Application No. 60/910,147, filed Apr. 4, 2007, are incorporated herein in their entirety by this reference.

STATEMENT OF GOVERNMENT INTEREST

Embodiments of present invention were developed using funds provided under United States Air Force contract number FA8650-06-C-6614. The U.S. government has certain rights in the invention.

US Referenced Citations (358)
Number Name Date Kind
1539637 Bronner May 1925 A
1686482 Windle Oct 1928 A
2080202 Drake May 1937 A
2317648 Siqveland Apr 1943 A
2419045 Whittaker Apr 1947 A
2590516 Von Breymann Mar 1952 A
2773501 Young Dec 1956 A
3022596 Cannon Feb 1962 A
3104448 Morrow et al. Sep 1963 A
3120845 Horner Feb 1964 A
3173417 Horner Mar 1965 A
3175554 Stewart Mar 1965 A
3269046 Schaefer Aug 1966 A
3507276 Burgess et al. Apr 1970 A
3543966 Ryan et al. Dec 1970 A
3664163 Foote May 1972 A
3815605 Schmidt et al. Jun 1974 A
3835860 Garreston Sep 1974 A
3893445 Hofsess Jul 1975 A
3991765 Cohen Nov 1976 A
4021920 Kirschner et al. May 1977 A
4099518 Baylis et al. Jul 1978 A
4124026 Berner et al. Nov 1978 A
4142517 Contreras Guerrero de Stavropoulos et al. Mar 1979 A
4170993 Alvarez Oct 1979 A
4185619 Reiss Jan 1980 A
4194505 Schmitz Mar 1980 A
4258722 Sessions et al. Mar 1981 A
4262676 Jamshidi Apr 1981 A
4306570 Matthews Dec 1981 A
4333459 Becker Jun 1982 A
4381777 Garnier May 1983 A
4441563 Walton, II Apr 1984 A
4469109 Mehl Sep 1984 A
4484577 Sackner et al. Nov 1984 A
4543966 Islam et al. Oct 1985 A
4553539 Morris Nov 1985 A
4605011 Naslund Aug 1986 A
4620539 Andrews et al. Nov 1986 A
4646731 Brower Mar 1987 A
4654492 Koerner et al. Mar 1987 A
4655226 Lee Apr 1987 A
4659329 Annis Apr 1987 A
4692073 Martindell Sep 1987 A
4711636 Bierman Dec 1987 A
4713061 Tarello et al. Dec 1987 A
4716901 Jackson et al. Jan 1988 A
4723945 Theiling Feb 1988 A
4758225 Cox et al. Jul 1988 A
4762118 Lia et al. Aug 1988 A
4772261 Von Hoff et al. Sep 1988 A
4787893 Villette Nov 1988 A
4793363 Ausherman et al. Dec 1988 A
4867158 Sugg Sep 1989 A
4919146 Rhinehart et al. Apr 1990 A
4921013 Spalink et al. May 1990 A
4935010 Cox et al. Jun 1990 A
4940459 Noce Jul 1990 A
4944677 Alexandre Jul 1990 A
4969870 Kramer et al. Nov 1990 A
4986279 O'Neill Jan 1991 A
5002546 Romano Mar 1991 A
5012605 Nishioka May 1991 A
5025797 Baran Jun 1991 A
5036860 Leigh et al. Aug 1991 A
5057085 Kopans Oct 1991 A
5074311 Hasson Dec 1991 A
5075994 Nishioka Dec 1991 A
5116324 Brierley et al. May 1992 A
5120312 Wigness et al. Jun 1992 A
5122114 Miller et al. Jun 1992 A
5133359 Kedem Jul 1992 A
5137518 Mersch Aug 1992 A
5139500 Schwartz Aug 1992 A
RE34056 Lindgren et al. Sep 1992 E
5172701 Leigh Dec 1992 A
5172702 Leigh et al. Dec 1992 A
5176643 Kramer et al. Jan 1993 A
5195985 Hall Mar 1993 A
5203056 Funk et al. Apr 1993 A
5207697 Carusillo et al. May 1993 A
5249583 Mallaby Oct 1993 A
5257632 Turkel et al. Nov 1993 A
5269785 Bonutti Dec 1993 A
5279306 Mehl Jan 1994 A
5312364 Jacobs May 1994 A
5313733 Meade May 1994 A
5324300 Elias et al. Jun 1994 A
5332398 Miller et al. Jul 1994 A
5333790 Christopher Aug 1994 A
5341823 Manosalva et al. Aug 1994 A
5348022 Leigh et al. Sep 1994 A
5357974 Baldridge Oct 1994 A
5368046 Scarfone et al. Nov 1994 A
5372583 Roberts et al. Dec 1994 A
5383859 Sewell, Jr. Jan 1995 A
5385553 Hart et al. Jan 1995 A
5400798 Baran Mar 1995 A
5405348 Anspach et al. Apr 1995 A
5423824 Akerfeldt et al. Jun 1995 A
5431655 Melker et al. Jul 1995 A
5437119 Womack Aug 1995 A
5451210 Kramer et al. Sep 1995 A
5484442 Melker et al. Jan 1996 A
D369858 Baker et al. May 1996 S
3529580 Kusunoki et al. Jun 1996 A
5526821 Jamshidi Jun 1996 A
5529580 Kusunoki et al. Jun 1996 A
5549565 Ryan et al. Aug 1996 A
5554154 Rosenberg Sep 1996 A
5556399 Huebner Sep 1996 A
5558737 Brown et al. Sep 1996 A
5571133 Yoon Nov 1996 A
5586847 Mattern, Jr. et al. Dec 1996 A
5591188 Waisman Jan 1997 A
5595186 Rubinstein et al. Jan 1997 A
5601559 Melker et al. Feb 1997 A
5632747 Scarborough et al. May 1997 A
5713149 Cady Feb 1998 A
5713368 Leigh Feb 1998 A
5724873 Hillinger Mar 1998 A
5733262 Paul Mar 1998 A
5752923 Terwilliger May 1998 A
5762639 Gibbs Jun 1998 A
5766221 Benderev et al. Jun 1998 A
5769086 Ritchart et al. Jun 1998 A
5779708 Wu Jul 1998 A
5800389 Burney et al. Sep 1998 A
5807277 Swaim Sep 1998 A
5810826 Akerfeldt et al. Sep 1998 A
5817052 Johnson et al. Oct 1998 A
5823970 Terwilliger Oct 1998 A
D403405 Terwilliger Dec 1998 S
D404458 Pruitt Jan 1999 S
5858005 Kriesel Jan 1999 A
5868711 Kramer et al. Feb 1999 A
5868750 Schultz Feb 1999 A
5873510 Hirai et al. Feb 1999 A
5885226 Rubinstein et al. Mar 1999 A
5891085 Lilley et al. Apr 1999 A
5911701 Miller et al. Jun 1999 A
5911708 Teirstein Jun 1999 A
5916229 Evans Jun 1999 A
5919172 Golba, Jr. Jul 1999 A
5924864 Loge et al. Jul 1999 A
5926989 Oliver, Sr. Jul 1999 A
5927976 Wu Jul 1999 A
5928238 Scarborough et al. Jul 1999 A
5941706 Ura Aug 1999 A
5941851 Coffey et al. Aug 1999 A
5960575 Chiovitt et al. Oct 1999 A
5960797 Kramer et al. Oct 1999 A
5980545 Pacala et al. Nov 1999 A
5993417 Yerfino et al. Nov 1999 A
5993454 Longo Nov 1999 A
6007496 Brannon Dec 1999 A
6017348 Hart et al. Jan 2000 A
6018094 Fox Jan 2000 A
6022324 Skinner Feb 2000 A
6027458 Janssens Feb 2000 A
6033369 Goldenberg Mar 2000 A
6033411 Preissman Mar 2000 A
6063037 Mittermeier et al. May 2000 A
6071284 Fox Jun 2000 A
6080115 Rubinstein et al. Jun 2000 A
6083176 Terwilliger Jul 2000 A
6086543 Anderson et al. Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6096042 Herbert Aug 2000 A
6102915 Bresler et al. Aug 2000 A
6106484 Terwilliger Aug 2000 A
6110128 Andelin et al. Aug 2000 A
6110129 Terwilliger Aug 2000 A
6110174 Nichter Aug 2000 A
6120462 Hibner et al. Sep 2000 A
6135769 Kwan Oct 2000 A
6154995 Lenoir et al. Dec 2000 A
6159163 Strauss et al. Dec 2000 A
6162203 Haaga Dec 2000 A
6183442 Athanasiou et al. Feb 2001 B1
6210376 Grayson Apr 2001 B1
6217561 Gibbs Apr 2001 B1
6221029 Mathis et al. Apr 2001 B1
6228049 Schroeder et al. May 2001 B1
6228088 Miller et al. May 2001 B1
6238355 Daum May 2001 B1
6247928 Meller et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6257351 Ark et al. Jul 2001 B1
6273715 Meller et al. Aug 2001 B1
6273862 Privitera et al. Aug 2001 B1
6283925 Terwilliger Sep 2001 B1
6283970 Lubinus Sep 2001 B1
6287114 Meller et al. Sep 2001 B1
6302852 Fleming et al. Oct 2001 B1
6308540 Lee Oct 2001 B1
6309358 Okubo Oct 2001 B1
6312394 Fleming Nov 2001 B1
6315737 Skinner Nov 2001 B1
6325806 Fox Dec 2001 B1
6328701 Terwilliger Dec 2001 B1
6328744 Harari et al. Dec 2001 B1
6349496 Neely Feb 2002 B1
6358252 Shapira Mar 2002 B1
6402701 Kaplan et al. Jun 2002 B1
6419490 Kitchings Weathers, Jr. Jul 2002 B1
6425888 Embleton et al. Jul 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6443910 Krueger et al. Sep 2002 B1
6468248 Gibbs Oct 2002 B1
6478751 Krueger et al. Nov 2002 B1
6488636 Bryan et al. Dec 2002 B2
6523698 Dennehey et al. Feb 2003 B1
6527736 Attinger et al. Mar 2003 B1
6527778 Athanasiou et al. Mar 2003 B2
6540694 Van Bladel et al. Apr 2003 B1
6547511 Adams Apr 2003 B1
6547561 Meller et al. Apr 2003 B2
6554779 Viola et al. Apr 2003 B2
6555212 Boiocchi et al. Apr 2003 B2
6582399 Smith et al. Jun 2003 B1
6585622 Shum et al. Jul 2003 B1
6595911 LoVuolo Jul 2003 B2
6595979 Epstein et al. Jul 2003 B1
6613054 Scribner et al. Sep 2003 B2
6616632 Sharp et al. Sep 2003 B2
6620111 Stehens et al. Sep 2003 B2
6626848 Nueenfeldt Sep 2003 B2
6626887 Wu Sep 2003 B1
6638235 Miller et al. Oct 2003 B2
6656133 Voegele et al. Dec 2003 B2
6689072 Kaplan et al. Feb 2004 B2
6702760 Krause et al. Mar 2004 B2
6702761 Damadian et al. Mar 2004 B1
6706016 Cory et al. Mar 2004 B2
6716192 Orosz, Jr. Apr 2004 B1
6716215 David et al. Apr 2004 B1
6716216 Boucher et al. Apr 2004 B1
6730043 Krueger et al. May 2004 B2
6730044 Stephens et al. May 2004 B2
6749576 Bauer Jun 2004 B2
6752768 Burdoff et al. Jun 2004 B2
6752816 Culp et al. Jun 2004 B2
6758824 Miller et al. Jul 2004 B1
6761726 Findlay et al. Jul 2004 B1
6796957 Carpenter et al. Sep 2004 B2
6846314 Shapira Jan 2005 B2
6849051 Sramek et al. Feb 2005 B2
6855148 Foley et al. Feb 2005 B2
6860860 Viola Mar 2005 B2
6875183 Cervi Apr 2005 B2
6875219 Arramon et al. Apr 2005 B2
6884245 Spranza Apr 2005 B2
6887209 Kadziauskas et al. May 2005 B2
6890308 Islam May 2005 B2
6905486 Gibbs Jun 2005 B2
6930461 Rutkowski Aug 2005 B2
6942669 Kurc Sep 2005 B2
6969373 Schwartz et al. Nov 2005 B2
7008381 Janssens Mar 2006 B2
7008383 Damadian et al. Mar 2006 B1
7008394 Geise et al. Mar 2006 B2
7025732 Thompson et al. Apr 2006 B2
7063672 Schramm Jun 2006 B2
7137985 Jahng Nov 2006 B2
7207949 Miles et al. Apr 2007 B2
7226450 Athanasiou et al. Jun 2007 B2
7229401 Kindlein Jun 2007 B2
7934333 Tuz May 2011 B1
8720097 Derman May 2014 B2
20010005778 Ouchi Jun 2001 A1
20010014439 Meller et al. Aug 2001 A1
20010047183 Privitera et al. Nov 2001 A1
20010053888 Athanasiou et al. Dec 2001 A1
20020042581 Cervi Apr 2002 A1
20020055713 Gibbs May 2002 A1
20020120212 Ritchart et al. Aug 2002 A1
20020138021 Pflueger Sep 2002 A1
20030028146 Aves Feb 2003 A1
20030032939 Gibbs Feb 2003 A1
20030036747 Ie et al. Feb 2003 A1
20030050574 Krueger Mar 2003 A1
20030114858 Athanasiou et al. Jun 2003 A1
20030125639 Fisher et al. Jul 2003 A1
20030153842 Lamoureux et al. Aug 2003 A1
20030191414 Reiley et al. Oct 2003 A1
20030195436 Van Bladel et al. Oct 2003 A1
20030195524 Barner Oct 2003 A1
20030199787 Schwindt Oct 2003 A1
20030216667 Viola Nov 2003 A1
20030225344 Miller Dec 2003 A1
20030225364 Kraft et al. Dec 2003 A1
20030225411 Miller Dec 2003 A1
20040019297 Angel Jan 2004 A1
20040019299 Ritchart et al. Jan 2004 A1
20040034280 Privitera et al. Feb 2004 A1
20040049128 Miller et al. Mar 2004 A1
20040064136 Papineau et al. Apr 2004 A1
20040073139 Hirsch et al. Apr 2004 A1
20040092946 Bagga et al. May 2004 A1
20040153003 Cicenas et al. Aug 2004 A1
20040158172 Hancock Aug 2004 A1
20040158173 Voegele et al. Aug 2004 A1
20040162505 Kaplan et al. Aug 2004 A1
20040191897 Muschler Sep 2004 A1
20040210161 Burdorff et al. Oct 2004 A1
20040215102 Ikehara et al. Oct 2004 A1
20040220497 Findlay et al. Nov 2004 A1
20050027210 Miller Feb 2005 A1
20050040060 Anderson et al. Feb 2005 A1
20050075581 Schwindt Apr 2005 A1
20050085838 Thompson et al. Apr 2005 A1
20050101880 Cicenas et al. May 2005 A1
20050113716 Mueller, Jr. et al. May 2005 A1
20050124915 Eggers et al. Jun 2005 A1
20050131345 Miller Jun 2005 A1
20050148940 Miller Jul 2005 A1
20050165328 Heske et al. Jul 2005 A1
20050165403 Miller Jul 2005 A1
20050165404 Miller Jul 2005 A1
20050171504 Miller Aug 2005 A1
20050182394 Spero et al. Aug 2005 A1
20050200087 Vasudeva et al. Sep 2005 A1
20050203439 Heske et al. Sep 2005 A1
20050209530 Pflueger Sep 2005 A1
20050215921 Hibner et al. Sep 2005 A1
20050228309 Fisher et al. Oct 2005 A1
20050261693 Miller et al. Nov 2005 A1
20060011506 Riley Jan 2006 A1
20060015066 Turieo et al. Jan 2006 A1
20060036212 Miller Feb 2006 A1
20060052790 Miller Mar 2006 A1
20060074345 Hibner Apr 2006 A1
20060079774 Anderson Apr 2006 A1
20060089565 Schramm Apr 2006 A1
20060122535 Daum Jun 2006 A1
20060129082 Rozga Jun 2006 A1
20060144548 Beckman et al. Jul 2006 A1
20060149163 Hibner et al. Jul 2006 A1
20060167377 Ritchart et al. Jul 2006 A1
20060167378 Miller Jul 2006 A1
20060167379 Miller Jul 2006 A1
20060184063 Miller Aug 2006 A1
20060189940 Kirsch Aug 2006 A1
20070016100 Miller Jan 2007 A1
20070049945 Miller Mar 2007 A1
20070149920 Michels et al. Jun 2007 A1
20070213735 Saadat et al. Sep 2007 A1
20070270775 Miller et al. Nov 2007 A1
20080015467 Miller Jan 2008 A1
20080015468 Miller Jan 2008 A1
20080045857 Miller Feb 2008 A1
20080045860 Miller et al. Feb 2008 A1
20080045861 Miller et al. Feb 2008 A1
20080045965 Miller et al. Feb 2008 A1
20080140014 Miller et al. Jun 2008 A1
20080215056 Miller et al. Sep 2008 A1
20080221580 Miller et al. Sep 2008 A1
Foreign Referenced Citations (24)
Number Date Country
2 454 600 Jan 2004 CA
10057931 Nov 2000 DE
517000 Dec 1992 EP
0807412 Nov 1997 EP
1099450 May 2001 EP
1314452 May 2003 EP
853349 Mar 1940 FR
2457105 May 1979 FR
2516386 Nov 1981 FR
2130890 Jun 1984 GB
1052433 Feb 1989 JP
9307819 Apr 1993 WO
9631164 Oct 1996 WO
9806337 Feb 1998 WO
9918866 Apr 1999 WO
9952444 Oct 1999 WO
0056220 Sep 2000 WO
0178590 Oct 2001 WO
0241792 May 2002 WO
2417921 May 2002 WO
2096497 Dec 2002 WO
2005110259 Nov 2005 WO
2005112800 Dec 2005 WO
2008081438 Jul 2008 WO
Non-Patent Literature Citations (62)
Entry
Åström, K.G., “Automatic Biopsy Instruments Used Through a Coaxial Bone Biopsy System with an Eccentric Drill Tip,” Acta Radiologica, May 1995; 36:237-242.
Åström, K. Gunnar O., “CT-guided Transsternal Core Biopsy of Anterior Mediastinal Masses,” Radiology May 1996; 199:564-567.
International Preliminary Report on Patentability, PCT/US2007/072202, 10 pages, Mailed Jan. 15, 2009.
International Preliminary Report on Patentability, PCT/US2007/072217, 11 pages, Mailed Feb. 12, 2009.
Australian Exam Report on Patent Application No. 2003240970, 2 pages, Oct. 15, 2007.
Liakat A. Parapia, Trepanning or trephines: a history of bone marrow biopsy, British Journal of Haematology, pp. 14-19, 2007.
Chinese Office Action, Application No. 2005800003261, (with English translation), (9 pgs), Jan. 16, 2009.
International Preliminary Report on Patentability, PCT/US/2007/078203, 13 pages, Mar. 26, 2009.
International Preliminary Report on Patentability, PCT/US/2007/078207, 10 pages, Mar. 26, 2009.
International Preliminary Report on Patentability, PCT/US/2007/078205, 10 pages, Mar. 26, 2009.
International Preliminary Report on Patentability, PCT/US/2007/078204, 11 pages, Apr. 2, 2009.
Vidacare Corporation Comments to Intraosseous Vascular Access Position Paper, Infusion Nurses Society, 6 pages, May 4, 2009.
International Preliminary Report on Patentability, PCT/US/2007/072209, 10 pages, May 14, 2009.
Japanese Office Action, Application No. 2004-508,670, (with English summary), (13 pgs), Apr. 21, 2009.
PCT Preliminary Report on Patentability, PCT/US/2008/050346, (8 pgs), Jul. 23, 2009.
Japanese Office Action, Application No. 2004-508,669, (with English summary), (9 pgs), Aug. 3, 2009.
Chinese Office Action, Application No. 200780000590.6, (with English translation), (13 pgs), Aug. 21, 2009.
European Office Action and Search Report, Application No. 09150973.7, (8 pgs), Oct. 23, 2009.
Chinese Office Action with English translation; Application No. 200910006631.3; pp. 13, Mar. 11, 2010.
Taiwan Office Action , Application No. 94102179 (with English translation); 12 pages, May 13, 2010.
Chinese Office Action with English translation; Application No. 200780001198.3; pp. 13, Apr. 27, 2010.
Pediatric Emergency, Intraosseous Infusion for Administration of Fluids and Drugs, www.cookgroup.com, 1 pg.
Michael Trotty, “Technology (A Special Report)—The Wall Street Journal 2008 Technology Innovation Awards—This years winners include: an IV alternative, a better way to make solar panels, a cheap, fuel efficient car and a better way to see in the dark”, The Wall Street Journal, Factiva, 5 pages.
Buckley et al., CT-guided bone biopsy: Initial experience with commercially available hand held Black and Decker drill, European Journal of Radiology 61, pp. 176-180.
Hakan et al., CT-guided Bone BiopsyPerformed by Means of Coaxial Bopsy System with an Eccentric Drill, Radiology, pp. 549-552, Aug. 1993.
European Search Report 08158699.2-1265, 4 pages, Aug. 2008.
International Search Report and Written Opinion, PCT/US2007/078204, 14 pages, Mailing Date May 15, 2008.
International Search Report and Written Opinion, PCT/US08/52943, 8 pages, Mailing Date Sep. 26, 2008.
European Office Action Communication, Application No. 08158699.2-1265/1967142, 10 pages, Nov. 4, 2008.
Gunal et al., Compartment Syndrome After Intraosseous Infusion: An Expiremental Study in Dogs, Journal of Pediatric Surgery, vol. 31, No. 11, pp. 1491-1493, Nov. 96.
International Search Report, PCT/US2006/025201, 12 pages, Mailing Date Feb. 7, 2008.
Communication Pursuant to Article 94(3) EPC, Application No. 05 712 091.7-1265, 4 pages, Apr. 8, 2008.
Notification of the First Chinese Office Action, Application No. 200580003261.8, 3 pages, Mar. 21, 2008.
International Search Report and Written Opinion, PCT/US08/500346, 12 pages, Mailing Date May 22, 2008.
PCT Invitation to Pay Additional Fees, PCT/US2007/072209, 9 pages, Mailing Dec. 3, 2007.
BioAccess.com, Single Use Small Bone Power Tool—How It Works, 1 pg, Printed Jun. 9, 2008.
International Search Report and Written Opinion, PCT/US2007/078203, 15 pages, Mailing Date May 13, 2008.
International Search Report and Written Opinion, PCT/US2007/072202, 17 pages, Mailing Date Mar. 25, 2008.
International Search Report and Written Opinion, PCT/US2007/078207, 13 pages, Mailing Date Apr. 7, 2008.
International Search Report and Written Opinion, PCT/US2007/078205, 13 pages, Mailing date Sep. 11, 2007.
European Office Action EP03731475.4, 4 pages, Oct. 11, 2007.
U.S. Appl. No. 11/427,501 Non Final Office Action, 14 pages, Mailed Aug. 7, 2008.
Richard O. Cummings et al., “ACLS-Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003.
International PCT Search Report, PCT/US03/17167, 8 Pages, Mailed Sep. 16, 2003.
International PCT Search Report, PCT/US03/17203, 8 Pages, Mailed Sep. 16, 2003.
International PCT Search Report PCT/US2004/037753, 6 Pages, Mailed Apr. 19, 2005.
Communication relating to the results of the partial International Search Report for PCT/US2005/002484, 6 pages, Mailed May 19, 2005.
International PCT Search Report and Written Opinion PCT/US2004/037753, 16 pages, Mailed Jul. 8, 2005.
International PCT Search Report and Written Opinion PCT/US2005/002484, 15 pages, Mailed Jul. 22, 2005.
Riley et al., “A Pathologist's Perspective on Bone Marrow Aspiration Biopsy: I. Performing a Bone Marrow Examination,” Journal of Clinical Laboratory Analysis 18, pp. 70-90, 2004.
Official Action for European Application No. 03756317.8 (4 pages), Dec. 28, 2006.
International Search Report and Written Opinion for International Application No. PCT/US2006/025201 (18 pages), Jan. 29, 2007.
“Proven reliability for quality bone marrow samples”, Special Procedures, Cardinal Health, 6 pages, 2003.
F.A.S.T. 1 Intraosseous Infusion System with Depth-Control Mechanism Brochure, 6 pages, 2000.
International Preliminary Report on Patentability PCT/US2005/002484, 9 pages, Mailed Aug. 3, 2006.
International Search Report, PCT/US2007/072209, 9 pages, Mailing Date Mar. 12, 2007.
International Search Report, PCT/US2007/072217, 9 pages, Mailing Date Mar. 12, 2007.
Pediatrics, “2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care of Pediatric and Neonatal Patients: Pediatric Advanced Life Support,” www.pediatrics.org, Official Journal of the American Academy of Pediatrics (26 pages), Feb. 21, 2007.
Chinese Office Action with English translation; Application No. 200880000182.5; 12 pages, Sep. 10, 2010.
Office Action issued in Chinese Application No. 200910006631.3, dated Mar. 22, 2011.
Non-Final Office Action, U.S. Appl. No. 10/449,476, 8 pages, Oct. 29, 2008.
Notification of First Chinese Office Action, Application No. 201410112780.9, dated May 27, 2015.
Related Publications (1)
Number Date Country
20080221580 A1 Sep 2008 US
Provisional Applications (1)
Number Date Country
60910147 Apr 2007 US